Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD
Hyundam Gu, Luis Antonio Díaz, Natalia Baeza, Francisco Idalsoaga, Xiao-Dong Zhou, Ming-Hua Zheng, Rakhi Maiwall, Shiv K Sarin, Anand V Kulkarni, Ramagundam Ramyasri, Fátima Higuera de la Tijera, Helena Cortez Pinto, Sofia Carvalhana, Rita Fernandes, Mohammad Qasim Khan, William Alazawi, Wenhao Li, Laura Temperley, David Marti-Aguado, Jordi Gratacós-Ginès, Elisa Pose, Maria Poca, Berta Cuyas, Pedro Montes, Fernando Javier Barreyro, Gustavo Ayares, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jimmy Che-To Lai, Cristiane Villela-Nogueira, Nathalie Leite, Gil Fernando Salles, Claudia Regina Lopes Cardoso, Daniza Contreras, José Antonio Velarde-Ruiz Velasco, Alceo Galimberti, Fernando Bessone, Francisco Javier Valentin-Cortez, Alejandra Mijangos-Trejo · 2026
Read Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD by Hyundam Gu, Luis Antonio Díaz, Natalia Baeza, Francisco Idalsoaga, Xiao-Dong Zhou, Ming-Hua Zheng, Rakhi Maiwall, Shiv K Sarin, Anand V Kulkarni, Ramagundam Ramyasri, Fátima Higuera de la Tijera, Helena Cortez Pinto, Sofia Carvalhana, Rita Fernandes, Mohammad Qasim Khan, William Alazawi, Wenhao Li, Laura Temperley, David Marti-Aguado, Jordi Gratacós-Ginès, Elisa Pose, Maria Poca, Berta Cuyas, Pedro Montes, Fernando Javier Barreyro, Gustavo Ayares, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jimmy Che-To Lai, Cristiane Villela-Nogueira, Nathalie Leite, Gil Fernando Salles, Claudia Regina Lopes Cardoso, Daniza Contreras, José Antonio Velarde-Ruiz Velasco, Alceo Galimberti, Fernando Bessone, Francisco Javier Valentin-Cortez, Alejandra Mijangos-Trejo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13412714.txt.
Description
Hyundam Gu and co-authors validate in 2026 whether blood-and-scan fibrosis pathways built for fatty liver disease work when alcohol also drives the damage. Noninvasive tests are well proven in metabolic liver disease, but evidence in combined metabolic-and-alcohol disease, and in alcohol-related disease alone, was thin. The study gathered 893 adults from 35 centres in 16 countries, judging scarring by biopsy or elastography scans.
Advanced fibrosis affected an estimated 45 percent of participants, more in the alcohol group than the combined group. The simple FIB-4 blood score performed acceptably in combined disease yet poorly in pure alcohol disease, while scan accuracy held across groups. The standard two-step pathway missed 6.8 percent of advanced cases overall, and 11.3 percent in alcohol disease.
Catalog record
| CREATOR | Hyundam Gu, Luis Antonio Díaz, Natalia Baeza, Francisco Idalsoaga, Xiao-Dong Zhou, Ming-Hua Zheng, Rakhi Maiwall, Shiv K Sarin, Anand V Kulkarni, Ramagundam Ramyasri, Fátima Higuera de la Tijera, Helena Cortez Pinto, Sofia Carvalhana, Rita Fernandes, Mohammad Qasim Khan, William Alazawi, Wenhao Li, Laura Temperley, David Marti-Aguado, Jordi Gratacós-Ginès, Elisa Pose, Maria Poca, Berta Cuyas, Pedro Montes, Fernando Javier Barreyro, Gustavo Ayares, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jimmy Che-To Lai, Cristiane Villela-Nogueira, Nathalie Leite, Gil Fernando Salles, Claudia Regina Lopes Cardoso, Daniza Contreras, José Antonio Velarde-Ruiz Velasco, Alceo Galimberti, Fernando Bessone, Francisco Javier Valentin-Cortez, Alejandra Mijangos-Trejo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |